Dame Margaret Brimble is already well known as one of New Zealand's most distinguished scientists. But of all her professional achievements so far, the latest tops them all, she says. "This is the biggest," the organic chemist says of the announcement last month that a drug based on a molecule she discovered more than two decades ago has received US Food and Drug Administration (FDA) approval.
The drug, trofinetide, is a synthetic version of a molecule essential for cognitive and motor function. In some people, a gene mutation inhibits formation of the molecule, causing a condition called Rett syndrome, which has symptoms that vary in severity, but are similar to cerebral palsy and autism. It almost exclusively affects females, emerging at around six to 18 months of age in an estimated one in 12,000 girls.
Brimble describes news of the FDA approval - a first for a neurological drug discovered in New Zealand - as "surreal".
"It's like a marathon where you've reached the end and can hand it over to someone else. Now it can go somewhere useful," says the Distinguished Professor and director of medicinal chemistry at the University of Auckland.
"As a female scientist, it's also really lovely to know it's a drug for females. With all the female scientists I've worked with over the years, I see this as a legacy for them."
Brimble's work on trofinetide has connected her to members of the Rett syndrome community for many years. She talks about receiving handcrafted gifts from US-based woman Katelin Lancaster, who has Rett syndrome and whose mother, Melinda, made necklaces featuring the trofinetide molecule for patients taking part in clinical trials for the drug.
This story is from the April 15-21 2023 edition of New Zealand Listener.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 15-21 2023 edition of New Zealand Listener.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
First-world problem
Harrowing tales of migrants attempting to enter the US highlight the political failure to fully tackle the problem.
Applying intelligence to AI
I call it the 'Terminator Effect', based on the premise that thinking machines took over the world.
Nazism rears its head
Smirky Höcke, with his penchant for waving with a suspiciously straight elbow and an open palm, won't get to be boss of either state.
Staying ahead of the game
Will the brave new world of bipartisanship that seems to be on offer with an Infrastructure Commission come to fruition?
Grasping the nettle
Broccoli is horrible. It smells, when being cooked, like cat pee.
Hangry? Eat breakfast
People who don't break their fast first thing in the morning report the least life satisfaction.
Chemical reaction
Nitrates in processed meats are well known to cause harm, but consumed from plant sources, their effect is quite different.
Me and my guitar
Australian guitarist Karin Schaupp sticks to the familiar for her Dunedin concerts.
Time is on my side
Age does not weary some of our much-loved musicians but what keeps them on the road?
The kids are not alright
Nuanced account details how China's blessed generation has been replaced by one consumed by fear and hopelessness.